molecular diagnostics

8 articles
BenzingaBenzinga··Lekha Gupta

Profusa Plunges 40% on $30M BioInsights Acquisition Despite Strategic Rationale

Profusa shares crashed 40% Tuesday after announcing $30M all-equity deal to acquire BioInsights' multi-omics diagnostics platform, expanding into molecular cancer detection.
PFSAstock declineacquisition
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider

Molecular Diagnostics Market to Nearly Triple to $43.5B by 2035 on Disease Detection Demand

Global molecular diagnostics market projected to grow from $18.26B in 2025 to $43.50B by 2035, driven by early disease detection demand and advanced technology adoption.
ILMNABTRHHBYTMODHR+1personalized medicineoncology
BenzingaBenzinga··Prnewswire

Co-Diagnostics Reports Sharp Revenue Decline, $46.9M Loss as Cash Reserves Dwindle

Co-Diagnostics ($CODX) posted $0.6M revenue and $46.9M net loss in 2025, down from prior year, amid strategic joint ventures and pipeline advancement.
CODXfinancial resultscommercialization
BenzingaBenzinga··Prnewswire

Co-Diagnostics Advances TB Testing in India Following WHO Guidance on Molecular Diagnostics

Co-Diagnostics ships PCR instruments and TB test kits to India for clinical studies, aligned with new WHO recommendations for molecular testing using tongue swabs.
CODXregulatory approvalIndia expansion
GlobeNewswire Inc.GlobeNewswire Inc.··Mordor Intelligence

Molecular Diagnostics Market Poised for Double-Digit Growth Through 2031

Global molecular diagnostics market projected to reach $33.51B by 2031 at 10.43% CAGR, driven by precision medicine adoption and genomic testing advances.
ILMNABTRHHBYTMODHR+6healthcare technologyprecision medicine
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Skeletal Dysplasia Market Set to Surge 54% to $5.37B by 2032

Global skeletal dysplasia market projected to grow from $3.48B (2026) to $5.37B (2032) at 7.42% CAGR, driven by diagnostic advances and innovative therapies.
PFENVSRAREREGNBMRNrare diseasebiologic therapy
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Respiratory Testing Market Set to Surge 56% by 2032 as Diagnostics Innovation Accelerates

Global respiratory testing market projected to reach $9.32B by 2032, growing 6.50% annually from $5.99B in 2025, driven by molecular diagnostics and telemedicine innovations.
MDTABTRHHBYTMOPHG+3strategic partnershipssupply chain resilience
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider

Veterinary Diagnostics Market Set to Double by 2035 Amid Rising Pet Care Demand

Global veterinary diagnostics market projected to double to $13.93 billion by 2035, driven by rising pet ownership and advanced medical care demand.
IDXXZTSveterinary diagnosticspet ownership